The Veteran's non-Hodgkin's lymphoma and leukemia are both rated at 100 percent for the entire period on appeal.
The deciding factor: The VA examiner indicated that the Veteran's conditions are in remission, with no current treatment ongoing. The NHL is described as an indolent and non-contiguous phase of low-grade NHL, warranting a 100% rating. The leukemia is rated at 0 percent due to intermittent myelosuppressive therapy or molecularly targeted therapy.
- Claimed conditions
- Non-Hodgkin's Lymphoma, Leukemia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- October 30, 2024
- Citation
- A24070325
Veterans Law Judge
Decisions by this judge: 1,893 · Granted: 31% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A24070325.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's service-connected PTSD and Leukemia have prevented him from obtaining or maintaining employment, leading to a grant of TDIU.
- Whole decision: Granted
The Veteran's service connection for leukemia, characterized as CLL, was improperly severed. Service connection for T-cell LGL leukemia is restored. The severance of service connection for NHL is upheld.
- Whole decision: Remanded (sent back)
The Board has decided to remand the case due to errors in duty to assist and needs additional medical opinions regarding the etiology of the Veteran's leukemia.
- Whole decision: Granted
The Board has restored a 100 percent rating for the Veteran's non-Hodgkin's lymphoma, effective April 1, 2025.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.